Sixteen years is a long time to hold a box office record, and it says something about how rough the Resident Evil movies have historically been received. That streak belonged to 2010’s Resident Evil: Afterlife, which opened to $60.12 million domestically and stood as the franchise’s high-water mark through five more films, a Netflix series, and one failed 2021 reboot. On September 18, 2026, writer-director Zach Cregger’s new Resident Evil finally beat it — and did so while also becoming, by a wide margin, the best-reviewed film the franchise has ever produced.
The film opened to $60 million domestically and $108 million worldwide against a reported $75–80 million budget, according to Deadline and Rotten Tomatoes’ box office desk, with $8.8 million in Thursday preview screenings — the ninth-highest preview total of 2026. For a genre that has spent years struggling to translate video games into hits (Rotten Tomatoes’ own recap noted that recent R-rated adaptations like Silent Hill and Doom “have not exactly lit up the box office”), Cregger’s film is now the rare exception, and by some distance the biggest.
A Director Who Said He’d Never Played the Games
Cregger comes into this the way few Resident Evil directors have: as a filmmaker with real momentum. He broke out with the 2022 horror hit Barbarian and followed it with 2025’s Weapons, both defined by a similar trick — tonal whiplash, structural surprises, and a willingness to let a scene be genuinely funny seconds before it turns terrifying. Rather than treat the Capcom source material with reverence, Cregger has said in press interviews that he wanted the film to feel like “Evil Dead II” more than any prior Resident Evil movie, and that he approached the project as a “love letter to the games” built from an original story rather than a retelling of one.
That original-story approach is itself a break from formula. This is technically the franchise’s second reboot and eighth theatrical film overall, but instead of adapting a specific game’s plot the way earlier entries loosely borrowed from Resident Evil and Resident Evil: Apocalypse, Cregger’s version is set in an alternate timeline that runs parallel to 1998’s Resident Evil 2 — familiar Raccoon City iconography and Umbrella Corporation menace, but no returning game characters and no obligation to hit established plot beats.
One Night, One Hospital, One Very Bad Delivery
The plot itself is deliberately small-scale for a franchise that has often gone big. Austin Abrams stars as Bryan, a medical courier making a delivery to Raccoon City General Hospital just as a viral outbreak tears through the building, trapping him inside with the infected. The supporting cast includes Zach Cherry, Kali Reis, and Paul Walter Hauser as Umbrella Corporation scientists whose fingerprints are all over the outbreak, and Johnno Wilson as an Umbrella enforcer sent in to clean up the mess. Filmed in Prague starting in October 2025 on an $80 million budget and shot for IMAX by cinematographer Dariusz Wolski, the film trades the sprawling, globe-hopping plots of the Milla Jovovich era for a contained, one-location survival story — a structure much closer to Resident Evil 2‘s claustrophobic police-station setting than to any of its own six cinematic predecessors.
The Reviews Are the Real Headline
For a franchise that has never once crossed the “Fresh” threshold on Rotten Tomatoes at the top level — its previous ceiling was 37% for 2016’s Resident Evil: The Final Chapter — Cregger’s film has landed in Certified Fresh territory, sitting in the mid-90s on the Tomatometer with critics citing its comic timing, practical creature effects, and its willingness to let scenes breathe into genuine dread before the gore hits. The site’s audience score has tracked closely behind, in the low-90s off several thousand verified ratings, which is an unusually tight critic-audience alignment for a legacy horror franchise. Variety reported that early reactions out of the film’s Fantastic Fest premiere on September 17 were already flagging it as a rare franchise reboot that plays for genre diehards and newcomers at once, rather than splitting the difference and satisfying neither.
That reception matters more than usual for a horror movie because of how word-of-mouth typically shapes R-rated horror’s box office trajectory. Films in the genre tend to front-load their opening weekend and drop sharply afterward if reviews and social buzz are mixed; a Certified Fresh score paired with strong audience marks is the profile that usually produces the opposite — a smaller weekend-to-weekend decline and a longer theatrical run. The Final Chapter, for context, made just $26.8 million domestically in 2017 but went on to gross more than $285 million internationally, almost entirely on the strength of overseas horror audiences with little regard for critical consensus. If Cregger’s film holds anywhere near that pattern with actual critical support behind it, its total haul could end up dwarfing its opening numbers.
What This Means for the Franchise Going Forward
Capcom’s Resident Evil games remain one of the most bankable properties in entertainment — the series has sold well over 175 million units lifetime — but the film side has spent two decades as a strange outlier: massively profitable overseas, critically ignored, and treated by Hollywood as B-movie counterprogramming rather than prestige IP. A $60 million domestic opening with reviews to match resets that math. It’s the kind of result that tends to fast-track a sequel conversation, and it arrives at a moment when studios are increasingly handing video-game adaptations to directors with a distinct creative voice rather than journeyman genre hands — the same bet that paid off for HBO’s The Last of Us and Illumination’s Super Mario Bros. Movie, in very different registers. Whether Cregger returns for a follow-up or hands the reins to someone else, his version has done something no Resident Evil movie managed before it: made the franchise’s next chapter a genuine event rather than an afterthought.